TAKEDA PHARMACEUTICAL CO LTD, Ten Percent Owner at Ovid Therapeutics, holds 3.76M shares in Phathom Pharmaceuticals (Ticker: PHAT), holds 6.72M shares in HilleVax, Inc (Ticker: HLVX), holds 7.53M shares in Ovid Therapeutics (Ticker: OVID). Most recently, TAKEDA PHARMACEUTICAL CO LTD Sold ― shares of Phathom Pharmaceuticals on Jan 25, 2024 for an estimated value of 30.00M.
What was TAKEDA PHARMACEUTICAL CO LTD’s latest transaction?
TAKEDA PHARMACEUTICAL CO LTD latest transaction was an Informative Sell of $30.00M.
What was TAKEDA PHARMACEUTICAL CO LTD's most profitable transaction?
TAKEDA PHARMACEUTICAL CO LTD’s most profitable transaction was an Informative Buy of OVID stock on November 22, 2019. The return on the trade was 119.20%.
What is TAKEDA PHARMACEUTICAL CO LTD's role in Ovid Therapeutics?
TAKEDA PHARMACEUTICAL CO LTD's role in Ovid Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.